HER-2/neu Gene Amplification Compared With HER-2/neu Protein Overexpression and Interobserver Reproducibility in Invasive Breast Carcinoma
Author:
Affiliation:
1. Department of Pathology, the University of Texas M.D. Anderson Cancer Center, Houston.
Publisher
Oxford University Press (OUP)
Subject
General Medicine
Link
http://academic.oup.com/ajcp/article-pdf/113/6/852/24905559/ajcpath113-0852.pdf
Reference22 articles.
1. HER-2 breast assay, linked to Herceptin wins FDA's okay;Graziano, C;CAP Today,1998
2. How should HER2 status be determined;McNeil, C;J Natl Cancer Inst,1999
3. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185 monoclonal antibody plus cisplatin in patients with HER-2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment;Pegram;J Clin Oncol,1998
4. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer;Gullick;Int J Cancer Suppl,1990
5. Comparison of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for the evaluation of HER-2/neu;Jacobs;J Clin Oncol,1999
Cited by 165 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical Outcomes and Efficacy of Human Epidermal Growth Factor Receptor 2–Targeted Therapy in Breast Cancer With Uncommon In Situ Hybridization Patterns or Discordant Immunohistochemistry;JCO Oncology Advances;2024-09
2. NDRGs in Breast Cancer: A Review and In Silico Analysis;Cancers;2024-03-29
3. Interpretable HER2 scoring by evaluating clinical guidelines through a weakly supervised, constrained deep learning approach;Computerized Medical Imaging and Graphics;2023-09
4. Application of 18F-PSMA-1007 PET/MR Imaging in Early Biochemical Recurrence of Prostate Cancer: Results of a Prospective Study of 60 Patients with Very Low PSA Levels ≤ 0.5 ng/mL;Cancers;2023-08-20
5. The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer;Cancers;2023-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3